- STAT+: Pharmalittle: We’re reading about Anthropic drug development goals, Trump drug plan snags, and moreAnthropic announced the availability of Claude Science, which optimizes its large language model for use in scientific labs and by drugmakersSTAT · 26d ago↗ source
- STAT+: More signs that GLP-1s may help with peripheral artery diseaseAnthropic will begin developing drugs, BridgeBio pockets a billion, and more biotech news from The ReadoutSTAT · 26d ago↗ source
- 92Bio revives a T cell engager it had transferred to AmgenA small California startup is reviving an experimental T cell engager that its scientists originally developed but had handed off to Amgen years ago. After repeatedly saying it would bring the drug…